| Members |
targetComponentId |
| Mycophenolic acid 180mg m/r capsule |
Mycophenolic acid (as mycophenolate sodium) 180 mg gastro-resistant oral tablet |
| Mycophenolic acid 360mg m/r capsule |
Mycophenolic acid (as mycophenolate sodium) 360 mg gastro-resistant oral tablet |
| Mycoplana bullata |
Brevundimonas bullata (organism) |
| Mycoplasma ellychniae |
Entomoplasma ellychniae |
| Mycoplasma lactucae |
Mesoplasma lactucae |
| Mycoplasma lepcaptivus |
Mycoplasma leonicaptivi (organism) |
| Mycoplasma lucivorax |
Entomoplasma lucivorax |
| Mycoplasma melaleucae |
Entomoplasma melaleucae |
| Mycoplasma somnilux |
Entomoplasma somnilux |
| Mycoplasma weynonii |
Mycoplasma wenyonii (organism) |
| Mycosis fungoides of extranodal AND/OR solid organ site |
Mycosis fungoides (clinical) |
| Mycosis fungoides of lymph nodes of axilla AND/OR upper limb |
Mycosis fungoides of lymph nodes of upper limb (disorder) |
| Mycosis fungoides of lymph nodes of axilla and upper limb |
Mycosis fungoides of lymph nodes of upper limb (disorder) |
| Mycosis leptothrica |
Tonsillitis due to Gram negative bacteria |
| Mycotic aneurysm due to bacterial endocarditis |
Endocarditis with infective aneurysm |
| Myelinated retinal nerve fibres |
Myelinated nerve fiber layer of retina |
| Myelinated retinal nerve fibres |
Myelinated nerve fiber layer of retina |
| Myelodysplasia |
Myelodysplasia of spinal cord |
| syndrome myélodysplasique avec dysplasie multilignée |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic syndrome with multilineage dysplasia |
Myelodysplastic neoplasm with low blasts (morphologic abnormality) |
| cytopénie réfractaire avec dysplasie de multiples lignées et sidéroblastes en anneau |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| anémie réfractaire avec sidéroblastes en anneau |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic syndrome with single lineage dysplasia |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic syndrome with single lineage dysplasia |
Myelodysplastic neoplasm with low blasts (morphologic abnormality) |
| anémie réfractaire (clinique) |
Myelodysplastic syndrome with low blasts (disorder) |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Myelodysplastic neoplasm with low blasts and SF3B1 mutation |
| Myeloid leukemia - category |
Myeloid leukaemia |
| Myeloid leukemia, no International Classification of Diseases for Oncology subtype |
Myeloid leukaemia |
| Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement |
Myeloid/lymphoid neoplasm with PDGFRB rearrangement |
| Myeloproliferative disease, no ICD-O subtype |
Myeloid proliferation |
| Myelosclerosis |
Myelofibrosis |
| Myelosclerosis with myeloid metaplasia |
Primary myelofibrosis |
| Myocardial infarction clinical management plan |
Myocardial infarction clinical management plan (record artifact) |
| Myoma, no International Classification of Diseases for Oncology subtype |
Myoma |
| Myometrial hyperplasia |
Hyperplasia of myometrium (disorder) |
| Myotenontoplasty |
Myotenoplasty |
| Myotenoplasty of hand |
Myotenoplasty |
| Myotension technique |
Muscle energy technique (procedure) |
| Myovirus group |
Family Myoviridae (organism) |
| N0 category |
American Joint Committee on Cancer cN0 (qualifier value) |
| N1: Metastasis in 1-3 lymph nodes |
cN1 |
| N1: Metastasis in 1-6 perigastric lymph nodes |
cN1 |
| N1: Metastasis in a single ipsilateral lymph node, < 3 cm in greatest dimension |
cN1 |
| N1: Metastasis in a single lymph node |
cN1 |
| N1: Metastasis in a single lymph node, < 2 cm in greatest dimension |
cN1 |
| N1: Metastasis in a single lymph node, <= 2 cm in greatest dimension |
cN1 |
| N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor |
cN1 |
| N1: Metastasis in perirectal lymph node or nodes |
cN1 |
| N1: Metastasis in regional lymph node or nodes |
cN1 |
| N1: Metastasis to movable ipsilateral axillary lymph node(s) |
cN1 |
| N1: Metastasis with a lymph node mass less than 2 cm in greatest dimension and 5 or fewer positive nodes, none larger than 2 cm in greatest dimension |
cN1 |
| N1: Pelvic or inguinal lymph node metastasis |
cN1 |
| N1: Regional lymph node metastasis |
cN1 |
| N1: Unilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa |
cN1 |
| N1a: 1-3 nodes involved |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1a: Metastasis in ipsilateral cervical lymph node(s) |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1a: Metastasis in single regional lymph node |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1a: Only micrometastasis, none > 0.2 cm in greatest dimension |
American Joint Committee on Cancer cN1a (qualifier value) |
| N1b: 4-7 nodes involved |
American Joint Committee on Cancer cN1b (qualifier value) |
| N1b: Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph node(s) |
American Joint Committee on Cancer cN1b (qualifier value) |
| N1b: Metastasis in multiple regional lymph nodes |
American Joint Committee on Cancer cN1b (qualifier value) |
| N1b: Metastasis to lymph node(s), any > 0.2 cm in greatest dimension |
American Joint Committee on Cancer cN1b (qualifier value) |
| N1c: >7 nodes involved |
cN1c |
| N2 category |
cN2 |
| N2: Bilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa |
cN2 |
| N2: Metastasis in 4 or more lymph nodes |
cN2 |
| N2: Metastasis in 7-15 perigastric lymph nodes |
cN2 |
| N2: Metastasis in a single ipsilat lymph node >3cm but <6cm in greatest dimension; or in multiple ipsilat lymph nodes, none >6cm in greatest dimension; or in bilat or contralat lymph nodes, none >6cm in greatest dimension |
cN2 |
| N2: Metastasis in a single lymph node, > 2 cm but <= 5 cm in greatest dimension, or multiple lymph nodes, none > 5 cm in greatest dimension |
cN2 |
| N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) |
cN2 |
| N2: Metastasis in more than one regional lymph node |
cN2 |
| N2: Metastasis to ipsilateral axillary lymph node(s) fixed to one another or to other structures |
cN2 |
| N2: Metastasis to unilateral internal iliac and/or inguinal lymph node(s) |
cN2 |
| N2: Metastasis with a lymph node mass >2 cm but <= 5 cm in greatest dimension, or more than 5 nodes positive, none > 5 cm; or evidence of extranodal extension of tumor |
cN2 |
| N2a: Metastasis in a single ipsilateral lymph node, > 3 cm but < 6 cm in greatest dimension |
American Joint Committee on Cancer cN2a (qualifier value) |
| N2b: Metastasis in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension |
cN2b |
| N2c: Metastasis in bilateral or contralateral lymph nodes, none > 6 cm in greatest dimension |
cN2c |
| N3 category |
cN3 |
| N3: Metastasis in >15 perigastric lymph nodes |
cN3 |
| N3: Metastasis in a lymph node > 5 cm in greatest dimension |
cN3 |
| N3: Metastasis in a lymph node > 6 cm in greatest dimension |
cN3 |
| N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph node(s) |
cN3 |
| N3: Metastasis in lymph node(s) |
cN3 |
| N3: Metastasis to ipsilateral internal mammary lymph node(s) |
cN3 |
| N3: Metastasis with a lymph node mass > 5 cm in greatest dimension |
cN3 |
| N3a: > 6 cm in dimension |
cN3a |
| N3b: extension to supraclavicular fossa |
American Joint Committee on Cancer cN3b (qualifier value) |
| NAD(P)H dehydrogenase (FMN) |
NAD(P)H dehydrogenase (quinone) |
| NX category |
cNX |
| œufs de Naboth du col de l'utérus |
Mucous retention cyst of cervix uteri (disorder) |
| Nabothian follicles on cervix |
Mucous retention cyst of cervix uteri (disorder) |
| Nabothian follicles on cervix |
Mucous retention cyst of cervix uteri (disorder) |
| Nabumetone 500mg dispersible tablet |
Nabumetone 2.5 mg/mL oral solution |
| Nail flap |
Flap (substance) |
| Nairobi sheep disease serogroup |
Nairobi sheep disease virus |
| Nape of neck flap |
Flap (substance) |
| Naphazoline hydrochloride + polyvinyl alcohol + zinc sulfate 0.02%wv/0.25%wv/0.25%wv drops |
Product containing only naphazoline and polyvinyl alcohol and zinc sulfate (medicinal product) |
| Naproxen 200mg/pseudoephedrine 120mg m/r tablet |
Product containing only naproxen and pseudoephedrine (medicinal product) |
FHIR